Newstral
Article
sacbee.com on 2023-12-15 14:00
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data For MRNA-1345, The Company’s Investigational Respiratory Syncytial Virus (RSV) Vaccine
Related news
- Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccinekansascity.com
- CPhase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meetingcharlotteobserver.com
- Respiratory syncytial virus spreading quickly this yearwhnt.com
- Regeneron scraps development of drug for respiratory syncytial viruswestfaironline.com
- What Is Respiratory Syncytial Virus And Why It Matters NowForbes
- TFive Questions About the Surging Outbreak of Respiratory Syncytial Virustoday.uconn.edu
- RL.A. County Supervisors Act to Curb Rising Respiratory Syncytial Virus Ratesrandomlengthsnews.com
- New Research Provides Hope In The Search For A Respiratory Syncytial Virus Vaccine- Part IIIForbes
- VInfluenza continues to decline in B.C.; respiratory syncytial virus remains high; COVID-19 remains relatively stablevoiceonline.com
- BCOVID-19: New studies show AstraZeneca’s efficacy matches mRNA vaccinesbusinessday.ng
- 90% efficacy for Pfizer's COVID-19 mRNA vaccine is strikingtimesofmalta.com
- G2022 Global Respiratory Syncytial Virus (RSV) Therapeutics Industry Status and Prospects Professional Market Research Report Standard Versiongalleonnews.com
- GGlobal Respiratory Syncytial Virus Fusion Protein Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028galleonnews.com
- CModerna’s Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Programcharlotteobserver.com
- Sinovac vaccine efficacy against Omicron increases following mRNA booster, Yale study findsyaledailynews.com
- CModerna and OpenAI Collaborate To Advance mRNA Medicinecharlotteobserver.com
- CModerna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congresscharlotteobserver.com
- MModerna (MRNA) Q3 Outcomes 2022mvtelegraph.com
- AstraZeneca buys respiratory drug businessThe Toledo Blade
- AVirginia becomes 11th state to allow terminally ill to access investigational medicationsaugustafreepress.com